Te
Non verificato

Tempus AI, Inc.

Di cosa scriviamo

IndustriaInformation TechnologySaluteSanitàTecnica
18/11/2025
Eventi
Web e Social Network
Tecnica
Software
Salute
Farmaceutica
Sanità
Information Technology
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
1.00
14/11/2025
Industria
Tecnica
Biotecnologia
Salute
Sanità
Farmaceutica
Oncologia
Scienza
Information Technology
Medicina - Varie
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
1.00
05/11/2025
Tecnica
Software
Biotecnologia
Salute
Farmaceutica
Information Technology
Oncologia
Eventi
Industria
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
1.00
04/11/2025
Information Technology
Tecnica
Salute
Sanità
Farmaceutica
Oncologia
Software
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Tempus Reports Third Quarter 2025 Results
1.00
28/10/2025
Web e Social Network
Fiere
Eventi
Salute
Information Technology
Tecnica
Tempus to Participate in the Stifel 2025 Healthcare Conference
1.00
21/10/2025
Sanità
Farmaceutica
Oncologia
Information Technology
Tecnica
Medicina - Varie
Biotecnologia
Tecnologie Varie
Salute
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Tempus to Report Third Quarter 2025 Financial Results on November 4
1.00
16/10/2025
Scienza
Oncologia
Sanità
Salute
Tecnica
Mercato del lavoro
Industria
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
1.00
15/10/2025
Information Technology
Biotecnologia
Tecnica
Salute
Sanità
Farmaceutica
Oncologia
Software
Medicina - Varie
Eventi
Industria
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
1.00
09/10/2025
Tecnica
Medicina - Varie
Associazioni/Professionisti
Salute
Sanità
Information Technology
Oncologia
Mercato del lavoro
Industria
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
1.00
22/09/2025
Industria
Scienza
Farmaceutica
Information Technology
Oncologia
Tecnica
Biotecnologia
Igiene alimentare
Salute
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0